Techne Corporation Releases Unaudited First Quarter Fiscal Year 2013 Financial Results

Minneapolis -- Techne Corporation's (NASDAQ:TECH) financial results for the quarter ended September 30, 2012 include the following highlights: - First quarter earnings were $25.7 million or $.70 per diluted share. Adjusted earnings for the quarter were $27.5 million (a decrease of 8.2% from the prior fiscal year period) or $.75 per diluted share. Earnings and [...]

Sigma-Aldrich Reports Q3 2012 Diluted EPS Of $0.92 And Diluted Adjusted EPS Of $0.94. Sales Increased 2% For Q3 2012. Reaffirms Full Year 2012 Adjusted Diluted EPS Of $3.80 to $3.90.

Q3 2012 Results (all percentages are to comparable periods in 2011) Q3 2012 reported sales increased 2% to $639 million. Sales grew organically by 2% with Research and Sigma-Aldrich Fine Chemicals ("SAFC") organic sales growth of 1% and 5%, respectively. Acquisitions contributed 6% to sales growth. Changes in foreign currency exchange rates reduced otherwise reportable [...]

Cellectis bioresearch Inc. wins a $6.9 million contract with The National Institutes of Health on iPS cells

Cambridge, Massachusetts (United States) - Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Alternext: ALCLS), announces that it has been awarded a second contract to provide services to the National Institutes of Health (NIH) and certain other government agencies. This multiple award, indefinite delivery/indefinite quantity (IDIQ) contract, has a maximum order [...]

Latest Versions of Alamut and Alamut HT Software Will Showcase at the ASHG Annual Meeting

SAN DIEGO, C.A. – Interactive Biosoftware (IBS), developer of Alamut, the world’s original mutation interpretation software, will showcase its groundbreaking Alamut 2.2 software at the internationally acclaimed American Society of Human Genetics Conference in San Francisco, CA from November 6th to November 10th. The new Alamut 2.2 upgrade is especially useful for Next Generation Sequencing [...]

Thermo Fisher Scientific Introduces Unique Extraction Workflow

BURLINGTON, ON, CANADA - Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the new Thermo Scientific Automated Nucleic Acid Extraction WorkStation. The fully automated workflow offers consistent, high-speed purifications by combining several Thermo Fisher tools into one turnkey solution. Designed to provide cost- and time-effective nucleic acid extraction, users can process [...]

Waters Corporation Reports Third Quarter 2012 Results

MILFORD, Mass.---- Waters Corporation (NYSE: WAT) reported today third quarter 2012 sales of $450 million, a 1% decrease in comparison to sales of $455 million in the third quarter of 2011. For the quarter, foreign currency translation reduced sales growth by 3%. On a GAAP basis, earnings per diluted share (E.P.S.) for the third quarter [...]

BINDER KT 115 Refrigerated Incubator Provides Accurate, Secure Conditions

BOHEMIA, N.Y. –– The new BINDER Inc. KT 115 refrigerated incubator utilizes energy-efficient, state-of-the-art Peltier refrigeration technology to provide secure, accurate control. With comprehensive program functions, the unit offers a wide range of capabilities for incubating biological materials and guarantees reproducible results. Functional chamber volume is 3.7 cu.ft. (104 liters), and the unit can run [...]

J.G. Finneran Introduces Versatility for Sample Vials

By combining a wide mouth with a tapered neck, the Versa Vial™, by J.G. Finneran Associates, simplifies the task of routinely preparing samples for autosamplers. The vase-like neck design of the Versa Vial™ has a 9mm opening, which is the largest target opening area available for any autosampler vial. With this unique design, it is [...]

Rainer Beaujean has been appointed as the new Chief Financial Officer of Gerresheimer AG

Düsseldorf, – Rainer Beaujean will join the Gerresheimer AG Management Board on December 1, 2012 and assume the function of CFO on February 1, 2013. The company’s current Chief Financial Officer, Hans-Jürgen Wiecha, is leaving the company on January 31, 2013 to pursue other career opportunities. The Supervisory Board has appointed Rainer Beaujean to the [...]

BioTime’s Subsidiary LifeMap Sciences, Inc. Announces the Launch of MalaCards – A Database of Human Diseases

ALAMEDA, Calif -- BioTime, Inc. (NYSE MKT: BTX) and LifeMap Sciences, Inc. announce the launch of MalaCards, a new database of human diseases that is based on their leading GeneCards® platform. MalaCards (www.malacards.org/) contains computerized “cards” classifying information relating to a wide array of human diseases. This novel research tool will aid researchers in studying [...]

Access IBO on Knowledge Center